Orchard Therapeutics plc (ORTX)
Jan 24, 2024 - ORTX was delisted (reason: acquired by Kyowa Kirin)
16.70
0.00 (0.00%)
Inactive · Last trade price
on Jan 23, 2024
Orchard Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2016 |
| Net Income | -72.92 | -150.66 | -144.58 | -151.98 | -163.42 | -230.5 | Upgrade
|
| Depreciation & Amortization | 2.67 | 2.74 | 2.33 | 2 | 1.68 | 1.2 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 5.65 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -3.03 | -0.31 | 1.51 | 0.77 | -0.68 | - | Upgrade
|
| Stock-Based Compensation | 12.48 | 16.01 | 22.54 | 27.96 | 19.42 | 6.77 | Upgrade
|
| Other Operating Activities | -36.46 | 20.02 | 10.17 | -7.05 | -8.35 | 88.48 | Upgrade
|
| Change in Accounts Receivable | -1.97 | -7.42 | -0.62 | 0.58 | 0.72 | -0.93 | Upgrade
|
| Change in Accounts Payable | 5.56 | 13.64 | -9.45 | -12.28 | -6.41 | 14.85 | Upgrade
|
| Change in Unearned Revenue | 3.86 | -0.27 | 13.12 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | 11.07 | 30.25 | -20.11 | 8.07 | -9.09 | 22.6 | Upgrade
|
| Operating Cash Flow | -93.32 | -75.99 | -125.1 | -126.27 | -166.13 | -97.54 | Upgrade
|
| Capital Expenditures | -1.09 | -6.51 | -2.35 | -12.67 | -4.37 | -4.03 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -0.89 | - | - | - | Upgrade
|
| Investment in Securities | -32.9 | 89.11 | -29.15 | 168.17 | -304.99 | - | Upgrade
|
| Other Investing Activities | 7.97 | 7.97 | 0.22 | 1.88 | - | - | Upgrade
|
| Investing Cash Flow | -26.02 | 90.56 | -32.17 | 157.38 | -309.36 | -4.03 | Upgrade
|
| Long-Term Debt Issued | - | - | 7.38 | - | 24.47 | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.79 | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -7.86 | -0.79 | 7.38 | - | 24.47 | - | Upgrade
|
| Issuance of Common Stock | 68.32 | 0.21 | 157.44 | 3.94 | 133.59 | 209.7 | Upgrade
|
| Repurchase of Common Stock | -0.2 | -0.02 | -0.39 | - | - | - | Upgrade
|
| Other Financing Activities | -0.99 | -0.1 | -6.36 | - | -0.61 | -4.2 | Upgrade
|
| Financing Cash Flow | 59.28 | -0.69 | 158.07 | 3.94 | 157.45 | 354.86 | Upgrade
|
| Foreign Exchange Rate Adjustments | 2.73 | -1.42 | -0.03 | 1.04 | 1.67 | -3.47 | Upgrade
|
| Net Cash Flow | -57.33 | 12.46 | 0.78 | 36.08 | -316.36 | 249.83 | Upgrade
|
| Free Cash Flow | -94.41 | -82.5 | -127.45 | -138.94 | -170.5 | -101.57 | Upgrade
|
| Free Cash Flow Margin | -432.30% | -364.16% | -7608.66% | -5354.22% | -6784.64% | -4892.49% | Upgrade
|
| Free Cash Flow Per Share | -5.48 | -6.45 | -10.28 | -13.97 | -18.29 | -45.02 | Upgrade
|
| Cash Interest Paid | 3.15 | 2.65 | 2.1 | 1.83 | 1.23 | - | Upgrade
|
| Cash Income Tax Paid | 0.16 | 0.16 | 1.65 | 1.01 | 1.47 | - | Upgrade
|
| Levered Free Cash Flow | -49.64 | -27.14 | -93.79 | -92.87 | -95.44 | -121.12 | Upgrade
|
| Unlevered Free Cash Flow | -47.27 | -25.22 | -92.23 | -91.41 | -94.48 | -121.12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.